Li Zhengwei, Guan Luxi, Luo Dong, Liu Meijun, Hu Haibo, Pan Xiangbin
Center of Structural Heart Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
PeerJ. 2025 Sep 10;13:e20022. doi: 10.7717/peerj.20022. eCollection 2025.
Patients with cyanotic congenital heart disease (CCHD) may continue to experience hypoxia and worsening cyanosis after undergoing a bidirectional Glenn procedure (BGP). Azygos or hemiazygos vein steal syndrome is a common cause of these complications. This study aimed to evaluate the safety and efficacy of transcatheter closure for azygos or hemiazygos vein steal syndrome following BGP in patients with CCHD.
A retrospective analysis was conducted on clinical data from 13 patients with CCHD who underwent transcatheter closure for azygos or hemiazygos vein steal syndrome after BGP at Fuwai Hospital between December 2007 and September 2019.
All azygos or hemiazygos veins were successfully closed. Femoral artery oxygen saturation (SO%) significantly increased after closure compared to before closure (86.94 ± 2.63% 74.98 ± 3.53%, < 0.001). The mean pulmonary arterial pressure (mPAP) also showed a statistically significant increase after closure but remained within normal ranges (12.08 ± 2.75 mmHg 10.54 ± 3.28 mmHg, = 0.020). The superior vena cava pressure (SVCP) showed almost no change before and after closure (11.08 ± 3.62 mmHg 12.31 ± 3.25 mmHg, = 0.059). During an average follow-up period of 25.69 ± 9.60 months, all patients showed significant improvement in cyanosis, and none experienced facial or neck edema. The saturation of pulse oximetry (SpO) was above 90% in all patients.
Transcatheter closure of azygos or hemiazygos vein steal syndrome in CCHD patients after BGP is a safe and effective intervention. It offers high technical success and favorable short- to mid-term outcomes, while avoiding the physical and psychological trauma associated with repeat thoracotomy.
患有青紫型先天性心脏病(CCHD)的患者在接受双向格林手术(BGP)后可能仍会经历缺氧和青紫加重的情况。奇静脉或半奇静脉盗血综合征是这些并发症的常见原因。本研究旨在评估经导管封堵治疗CCHD患者BGP术后奇静脉或半奇静脉盗血综合征的安全性和有效性。
对2007年12月至2019年9月期间在阜外医院接受BGP术后因奇静脉或半奇静脉盗血综合征而行经导管封堵治疗的13例CCHD患者的临床资料进行回顾性分析。
所有奇静脉或半奇静脉均成功封堵。封堵后股动脉血氧饱和度(SO%)较封堵前显著升高(86.94±2.63%对74.98±3.53%,P<0.001)。平均肺动脉压(mPAP)封堵后也有统计学意义的升高,但仍在正常范围内(12.08±2.75 mmHg对10.54±3.28 mmHg,P = 0.020)。上腔静脉压力(SVCP)封堵前后几乎无变化(11.08±3.62 mmHg对12.31±3.25 mmHg,P = 0.059)。在平均25.69±9.60个月的随访期内,所有患者青紫均有显著改善,且无一例出现面部或颈部水肿。所有患者脉搏血氧饱和度(SpO)均高于90%。
CCHD患者BGP术后经导管封堵奇静脉或半奇静脉盗血综合征是一种安全有效的干预措施。它具有较高的技术成功率和良好的中短期疗效,同时避免了再次开胸手术带来的身体和心理创伤。